Overview
Elizabeth Henschel is a Nurse Practitioner in Wyoming, Michigan. Ms. Henschel is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), ALK-Positive Non-Small Cell Lung Cancer, Nonalcoholic Steatohepatitis (NASH), and Non-Alcoholic Fatty Liver Disease.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Additional Areas of Focus
Henschel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Spectrum Health Primary Care Partners
Sarah Raden is a Nurse Practitioner in Kentwood, Michigan. Ms. Raden has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Small Lymphocytic Lymphoma (SLL), ALK-Positive Non-Small Cell Lung Cancer, Smoldering Multiple Myeloma, and Malabsorption. Ms. Raden is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Henschel isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)